← Back
$OCUL All transactions

OCULAR THERAPEUTIX, INC

A

$ Value

$0

Shares

44,000

Price

$0

Filed

Jun 13

Insider

Name

Graves Adrienne L

Title

CIK

0001326192

Roles

Director

Transaction Details

Transaction Date

2025-06-11

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

44,000

Footnotes

On June 11, 2025, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Company"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date. | Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date.

Filing Info

Accession No.

0001104659-25-059379

Form Type

4

Issuer CIK

0001393434

Graves Adrienne L's History

Date Ticker Type Value
2026-04-20 IRD A $0
2026-01-01 IRD A
2025-06-20 HROW A $0
2025-06-11 OCUL A $0
2025-06-11 OCUL A $0
2025-04-30 IRD A $0
2025-04-30 IRD A $0

Other Insiders at OCUL (90d)

Insider Bought Sold Last
LINDSTROM RICHARD L MD $461K 2026-02-20
Heier Jeffrey S.
Chief Scientific Officer
$25K 2026-02-23
Dugel Pravin
See Remarks
$1.3M 2026-04-09
Notman Donald
Chief Operating Officer
$205K 2026-02-12
Kaiser Peter
Chief Development Officer
$23K 2026-02-23
Nayak Sanjay
Chief Strategy Officer
$108K 2026-02-23
Waheed Nadia
Chief Medical Officer
$98K 2026-02-20
Robinson David Wayne
Global CCO
2026-01-21